Learn more →
Back to Expert Scholars
Translational Medicine / 转化医学Neuro-Oncology, WHO 2021 Glioma Classification

Michael Weller

MD

🏢University Hospital Zurich🌐Switzerland

Professor and Chairman, Department of Neurology

94
h-index
0
Key Papers
0
Key Contributions

👥Biography 个人简介

Michael Weller has been instrumental in shaping the WHO 2021 CNS tumor classification, which integrates molecular markers into glioma diagnosis. He is co-chair of the European Association for Neuro-Oncology (EANO) and has contributed extensively to consensus guidelines for GBM management. His research has clarified the predictive value of MGMT methylation across different GBM treatment regimens and explored immunotherapy strategies for glioma.

Share:

🧪Research Fields 研究领域

WHO 2021 CNS tumor classification
glioma molecular markers
IDH wild-type GBM
MGMT promoter methylation
glioma immunotherapy

🎓Key Contributions 主要贡献

Representative Works 代表性著作

📄Data Sources 数据来源

Last updated: 2026-04-01 | All information from publicly available academic sources

关注 Michael Weller 的研究动态

Follow Michael Weller's research updates

留下邮箱,当我们发布与 Michael Weller(University Hospital Zurich)相关的新研究或访谈时,我们会通知你。

我们不会泄露你的信息,也不会发送无关内容。随时可以退订。

Explore More Experts

Discover the researchers shaping the future of cancer treatment